INTRODUCTION
============

Mitochondria harbor between 1000 (yeast) and 1500 (human) different proteins. With a few exceptions of the proteins encoded by the mitochondrial genome, almost the entire organellar proteome is built up via import of nuclear-encoded precursor proteins ([@B10]; [@B26]; [@B21]; [@B8]; [@B30]; [@B28]). Approximately 70% of these precursors possess N-terminal presequences, which direct them to the protein import machinery and promote their translocation across the two mitochondrial membranes ([@B9]; [@B22]; [@B10]; [@B34]). Mitochondrial presequences are typically positively charged amphipathic helices and require the membrane potential Δψ as a major driving force for preprotein translocation across the inner membrane ([@B9]; [@B10]; [@B26]; [@B34]; [@B8]; [@B12]; [@B30]; [@B28]). On emerging on the matrix side, the presequence is usually cleaved by the mitochondrial processing protease (MPP), a heterodimer consisting of the two subunits Mas1 and Mas2. Presequence processing by MPP is essential for cell viability, and presequence peptides resulting from MPP processing have to be efficiently degraded because they are toxic for the cell ([@B13]; [@B36]; [@B9]; [@B23]; [@B32]; [@B16]; [@B27]; [@B33]). We recently sowed that this toxicity is due to an impairment of the MPP activity by feedback inhibition, which in turn causes accumulation of immature precursor proteins and eventually an imbalanced organellar proteome ([@B24]; [@B5]). Of note, amyloid β peptides, which accumulate in mitochondria of Alzheimer's disease patients ([@B11]; [@B3]), also limit peptide degradation capacity and lead to accumulation of immature precursor proteins ([@B24]). Presequence peptide degradation is mediated by metalloproteases---for example, PreP in humans (also known as PITRM1) and plants or their homologue, Cym1, in yeast mitochondria ([@B14]; [@B11]; [@B3],b; [@B23], [@B24]; [@B15]; [@B32]).

Here we identify Ste23, a homologue of human insulin-degrading enzyme (IDE), as a novel protease in the mitochondrial matrix of yeast. Mitochondrial Ste23 cooperates with Cym1 in efficient peptide clearance and can also degrade amyloid β peptides such as human IDE and PreP. Moreover, we show by in vitro assays as well as in vivo that Ste23 is required for functional presequence processing machinery.

RESULTS AND DISCUSSION
======================

Identification of Ste23 as a peptide-degrading protease in the mitochondrial matrix
-----------------------------------------------------------------------------------

The metalloprotease Cym1 was the only known peptide-degrading enzyme in the yeast mitochondrial matrix. Peptide degradation activity can be monitored in soluble mitochondrial extracts ([@B3]; [@B24]). Indeed, the degradation kinetics tested thus far revealed an apparently complete loss of peptide degradation capacity in the absence of Cym1 ([@B3]; [@B24]). Here we analyzed the degradation of presequence peptides in wild-type and *cym1Δ* soluble mitochondrial extracts for longer time spans and observed residual peptide clearance activity even in the absence of Cym1 ([Figure 1A](#F1){ref-type="fig"}). Of note, we observed such an activity also for the degradation of amyloid β peptides (Supplemental Figure S1, A and B). This led us to speculate about the presence of an additional mitochondrial protease activity involved in peptide degradation. To narrow the class of protease to which this activity could be assigned, we monitored peptide degradation (on prolonged incubation) in *cym1Δ* soluble mitochondrial extracts in the presence of protease inhibitors. In contrast to inhibition of serine proteases by phenylmethylsulfonyl fluoride (PMSF), the presence of *o*-phenanthroline/EDTA strongly inhibited peptide degradation capacity in the absence of Cym1, indicating a further, different metalloprotease involved in this process ([Figure 1B](#F1){ref-type="fig"}). To uncover such an enzyme, we searched the yeast genome for a putative metalloprotease with unknown function and a high prediction score for the presence of a mitochondrial presequence at its N-terminus. We found the open reading frame YLR389C encoding Ste23 with a high score prediction of 0.975 (MitoProt II) for a mitochondrial presequence ([@B7]). This protein has been implicated in pro--a-factor processing and was therefore named *STErile23* ([@B1]). However, this role has been challenged by the fact that Ste23 is expressed in cells that do not produce a-factor, and it was proposed that Ste23 might be involved in other physiological functions ([@B4]). Of note, [@B4] found that proteolytic activity of Ste23 does not require the annotated N-terminal 53 amino acids and speculated about the misassignment of the *STE23* gene. We asked whether the N-terminus might be explained by the presence of a cleavable mitochondrial presequence. To test this, we generated \[^35^S\]Ste23 precursor protein by in vitro transcription/translation. On incubation with isolated mitochondria, the \[^35^S\]Ste23 precursor is imported in a membrane potential--dependent manner and processed into a shorter variant reflecting the mature protein ([Figure 2A](#F2){ref-type="fig"}, lanes 1--5). Import of Ste23 requires the protein import machinery (revealed by the dependence on the central import receptor Tom22; [Figure 2A](#F2){ref-type="fig"}, lanes 6--9), and its presequence is cleaved by MPP (shown by import into *mas1* mutant mitochondria \[ [@B35]\]; [Figure 2B](#F2){ref-type="fig"}). To confirm mitochondrial matrix localization of endogenous Ste23, we generated specific and affinity-purified antibodies. Ste23 is protected by externally added Proteinase K (PK) under isoosmotic and hypoosmotic conditions (which enable access of PK to the intermembrane space) but is degraded by PK when both membranes are lysed by the detergent Triton X-100 ([Figure 2C](#F2){ref-type="fig"}, lanes 1--6). The protein can also be easily extracted by alkaline pH into the soluble protein fraction ([Figure 2C](#F2){ref-type="fig"}, lanes 7 and 8). In summary, Ste23 is imported into mitochondria via a cleavable presequence and localizes to the matrix.

![Detection of a peptide-degrading activity in *cym1*Δ mitochondria. (A) Degradation of Cox4^1--17^ (lanes 1--8) and Sod2^1--18^ (lanes 9--16) presequence peptides in soluble extracts of mitochondria from wild-type (WT) and *cym1Δ* yeast strains. Samples were analyzed by SDS--PAGE and immunodecoration. Aco1 and Mas1 served as loading controls. (B) Degradation of Cox4^1--17^ presequence peptide in mitochondrial extract from *cym1Δ* strain in the presence or absence of protease inhibitors (5 mM EDTA and 1 mM *o*-phenanthroline \[o-Phe\] or 1 mM PMSF). Ssc1, loading control.](997fig1){#F1}

![The metalloprotease Ste23 localizes to the mitochondrial matrix. (A) Radiolabeled Ste23 precursor was incubated with WT and *tom22*Δ mitochondria for various times. Where indicated, the membrane potential (Δψ) was dissipated before the import reaction. Samples were treated with PK and analyzed via SDS--PAGE and autoradiography. m, mature; p, precursor. (B) Import of \[^35^S\]Ste23 precursor into mitochondria isolated from WT and *mas1* temperature-sensitive mutant strains ([@B34]) after shifting of the culture for 6 h to 37°C. Impaired MPP activity in *mas1* allows import but not presequence processing of Ste23 precursor (lane 4 vs. lane 3). Samples were treated as in A. (C) Mitochondria were subjected to hypoosmotic swelling (lanes 1--4), Triton X-100 treatment (lanes 5 and 6), or carbonate extraction at pH 11.5 (lanes 7 and 8). Samples were analyzed by SDS--PAGE and immunodecoration. Prot. K, Proteinase K; P, pellet; SN, supernatant.](997fig2){#F2}

To study the potential role of Ste23 in presequence degradation, we generated wild-type Ste23 and the variant Ste23^E121Q^ with a mutation in the predicted catalytic site by cell-free translation ([@B4]). Wild-type Ste23 but not the inactive variant can efficiently degrade the presequence peptide of Cox4 and also amyloid β peptide ([Figure 3A](#F3){ref-type="fig"}). Degradation of presequence peptides in soluble mitochondrial fractions of wild type and an *ste23Δ* mutant revealed a delay in peptide clearance in the absence of Ste23 ([Figure 3B](#F3){ref-type="fig"}; note that Cym1 is still present in these samples). Similarly, we also observed a delay of the degradation of amyloid β peptides in *ste23Δ* samples compared with wild type (Supplemental Figure S2A). Taken together, the results indicate that Ste23 is a novel mitochondrial matrix protease that appears to play a role in peptide degradation.

![Cooperation of Ste23 and Cym1 in mitochondrial peptide degradation. (A) In vitro--synthesized Ste23 protein with a C-terminal hexahistidine tag (WT or E121Q mutation in the catalytic center) was incubated with Cox4 presequence peptide and amyloid β peptide (Aβ^1--28^) for indicated periods of time. Samples were analyzed by SDS--PAGE, followed by immunodecoration with Cox4 presequence specific antibodies and anti-histidine to detect Ste23. (B) Soluble extracts from WT and *ste23Δ* mitochondria were supplemented with Cox4^1--17^ (lanes 1--8) and Sod2^1--18^ (lanes 9--16) presequence peptides and incubated for indicated time. Peptide degradation was monitored by SDS--PAGE and immunodecoration. Mge1, loading control. (C) Double deletion of STE23 and CYM1 results in severe growth defect. Strains were grown under respiratory growth conditions (YPG) at 19°C. (D) Soluble mitochondrial fractions from *cym1Δ* and *ste23Δcym1Δ* yeast cells were incubated with Cox4 presequence peptides or amyloid β peptides for indicated time. Samples were analyzed by SDS--PAGE and immunodecoration. Mas1 served as loading control.](997fig3){#F3}

Ste23 and Cym1 form a cooperative system of presequence peptide degradation
---------------------------------------------------------------------------

Owing to relatively mild impairment of peptide degradation in *ste23Δ* mitochondria ([Figure 3B](#F3){ref-type="fig"} and Supplemental Figure S2A), in which Cym1 is still present (and conversely; [Figure 1A](#F1){ref-type="fig"} and Supplemental Figure S1, A and B), we wondered whether Ste23 and Cym1 tightly cooperate to ensure efficient peptide clearance. We asked whether the absence of both proteases, Ste23 and Cym1, might more severely affect mitochondrial peptide degradation capacity and eventually cell viability. Indeed, whereas single-deletion mutants of Cym1 and Ste23 grow like wild type at low temperature, their simultaneous deletion leads to a severe growth defect ([Figure 3C](#F3){ref-type="fig"}). This points toward cooperative action of the enzymes that is important for cell viability. This cooperative system of Ste23 and Cym1 is also reflected by the strongly impaired peptide degradation capacity (tested for Cox4 presequence and amyloid β peptides) in mitochondrial extracts from the double mutant *ste23Δcym1Δ * compared with the (already impaired) activity of *cym1Δ* samples ([Figure 3D](#F3){ref-type="fig"}).

Ste23 is required for efficient preprotein maturation
-----------------------------------------------------

Impaired peptide degradation in *cym1Δ *mitochondria affects the activity of the essential protease MPP, and this is likely caused by competition of accumulating presequence peptides with the incoming precursor proteins for binding to MPP ([@B36]; [@B31]; [@B25]; [@B24]). As a consequence, immature precursor proteins accumulate within the organelle, finally leading to impaired mitochondrial proteostasis ([@B24]). We wondered whether loss of Ste23 also affects MPP activity and therefore tested first a potential genetic interaction of *STE23* and MPP. Indeed, when we deleted *STE23* in the MPP mutant strain *mas1*, the cells were not viable on respiratory growth medium even at low temperature, indicating a functional link between *STE23* and MPP ([Figure 4A](#F4){ref-type="fig"}). A very similar phenotype is observed for the *mas1cym1Δ* double mutant ([Figure 4A](#F4){ref-type="fig"}; [@B24]). We then sought to analyze MPP activity in soluble mitochondrial extracts from *ste23Δcym1Δ* double- and single-mutant strains. Presequence processing of \[^35^S\]Sod2 precursors was severely impaired in the double-mutant compared with the already decreased activity in the *cym1Δ  *and *ste23Δ* single-mutant samples ([Figure 4B](#F4){ref-type="fig"}). To test whether the impaired MPP activity might also be detectable in vivo, we inspected typical mitochondrial precursor proteins with classical N-terminal presequences by immunoblotting mitochondria isolated from wild-type, single-deletion, and *ste23Δcym1Δ* double-deletion strains ([Figure 4C](#F4){ref-type="fig"}). Immature precursors can be identified either by their slower migration during electrophoresis or presequence-specific antibodies that recognize only the precursor and not the mature protein ([@B24]). Whereas lack of Ste23 alone did not reveal detectable precursors (unlike in *cym1Δ  *mitochondria), deletion of both proteases led to a severe increase of nonprocessed immature mitochondrial proteins ([Figure 4, C and D](#F4){ref-type="fig"}). These findings support our view that efficient peptide clearance is an important requirement for proper functioning of the presequence-processing protease MPP.

![Peptide clearance by Ste23 and Cym1 is required for functional presequence processing machinery. (A) Synthetic lethality of *mas1ste23Δ* and *mas1cym1Δ* double mutants. Strains were grown under fermentative (YPD) or respiratory (YPG) conditions at 23°C. (B) Presequence-processing activity in soluble mitochondrial extracts from indicated yeast strains was analyzed by incubation with radiolabeled Sod2 precursor, followed by SDS--PAGE and autoradiography. c, cleaved Sod2 protein; p, precursor. (C) Immunoblot analysis of mitochondria isolated from WT, *ste23Δ, cym1Δ*, and *ste23Δcym1Δ* yeast cells. i, processing intermediate; m, processed, mature protein. (D) Levels of nonprocessed preproteins (p) analyzed in C were quantified. Quantifications represent mean ± SEM (*n* = 3). (E) Overexpression of Ste23 in *cym1*Δ cells stimulates presequence processing of radiolabelled Sod2 precursor in soluble mitochondrial extracts. c, cleaved Sod2 protein; ev, empty vector; p, precursor. (F) Ste23 rescues loss of Cym1 function in vivo. Overexpression of Ste23 from pRS425 plasmid restores viability of *cym1*Δ cells at 37°C.](997fig4){#F4}

To gain further independent evidence of functional cooperation of Cym1 and Ste23 in this process, we overexpressed Ste23 in the *cym1Δ* mutant strain. We found that the presequence-processing activity of MPP can be stimulated by overexpression of Ste23 in the absence of Cym1 ([Figure 4E](#F4){ref-type="fig"}). Similarly, Cym1 overexpression facilitated MPP activity in *ste23Δ* samples (Supplemental Figure S2B). Moreover, overexpression of Ste23 can rescue the lethal growth phenotype of the *cym1Δ  *strain at higher temperature, strongly supporting a cooperative role of both enzymes in mitochondrial peptide clearance, which is an important requirement for a functional presequence-processing machinery ([Figure 4F](#F4){ref-type="fig"}).

Our results shed new light on a possible involvement of human IDE in mitochondrial peptide clearance and preprotein maturation. Human IDE is mainly localized to the cytosol; however, a novel variant generated from an initiation codon upstream of the canonical start site that encodes a putative presequence has been identified, and IDE was proposed to cleave a targeting peptide in vitro ([@B18]). Of note, although high-throughput proteomic studies detected IDE in mitochondrial fractions ([@B6]), the in vivo role of mitochondrial IDE and the submitochondrial localization of the authentic protein had not been studied. Of interest, we find that a significant fraction of the IDE homologue Ste23 also localizes to the cytosol, like its human counterpart (Supplemental Figure S2C). Besides insulin and several further peptides, IDE can also degrade amyloid β peptides, and [@B17] found that inhibition of IDE leads to increased levels of mitochondrial amyloid β peptides in vitro. It is therefore tempting to speculate that human IDE, like the yeast homologue Ste23, also localizes to the mitochondrial matrix, where it may contribute to the clearance of presequence peptides (and amyloid β peptides) and consequently ensure proper functioning of the presequence processing machinery. In plants, a novel protease (organellar oligopeptidase \[OOP\]) has been identified in chloroplasts and mitochondria of *Arabidopsis thaliana* that can degrade targeting peptides in cooperation with AtPreP ([@B15]). Unlike Ste23 and human IDE, which belong to the M16 clan of proteases ([@B4]), OOP is an M3 family protease. It will be interesting to see whether the plant OOP/PreP system might also be important for efficient preprotein maturation.

MATERIALS AND METHODS
=====================

Yeast strains and growth conditions
-----------------------------------

The *Saccharomyces cerevisiae* strains used in this study are listed in Supplemental Table S1. Deletion of the open reading frame was performed using the deletion cassettes pFa6a-kanMX6 and pFa6a-HIS3MX6 by homologous recombination ([@B29]; [@B19]). The integration of the deletion cassette was confirmed by PCR and Western blotting. Yeast cells were grown on YPD medium (1% \[wt/vol\] yeast extract, 2% \[wt/vol\] Bacto Peptone, 2% \[wt/vol\] glucose), YPS medium (containing 2% \[wt/vol\] sucrose instead of glucose), or YPG medium (containing 3% \[wt/vol\] glycerol instead of glucose) at 19, 23, 30, or 37°C. For overexpression of Ste23, wild-type and *cym1∆* cells were transformed with pRS425^Ste23^ or the empty plasmid (pRS425^ev^). For overexpression of Cym1, the *ste23∆* yeast strain was transformed with pRS425^Cym1^ or the empty plasmid (pRS425^ev^). Cells were grown on minimal medium (2% \[wt/vol\] glucose, 0.67% \[wt/vol\] yeast nitrogen base without amino acids, 0.07% \[wt/vol\] CSM-LEU dropout medium). For growth tests, yeast cells were grown on YPD medium at 30°C, spotted on YPD or YPG agar plates in serial dilutions, and incubated at various temperatures.

Isolation of mitochondria
-------------------------

Isolation of mitochondria from *S. cerevisiae* was performed according to standard protocols ([@B20]). Yeast cells grown on YPG, YPD, or YPS were harvested by centrifugation. To obtain spheroplasts, the yeast pellet was treated with dithiothreitol (DTT) buffer (10 mM DTT, 100 mM Tris-H~2~SO~4~, pH 9.4) and subsequently with Zymolyase buffer (1.2 M sorbitol, 20 mM K~2~HPO~4~-HCl, pH 7.4) containing 3 mg Zymolyase/g wet weight yeast cells. Spheroplasts were homogenized by 20 strokes with a glass-Teflon potter. After homogenization, cell debris and nuclei were removed by centrifugation at 1500 × *g* at 4°C. Mitochondria were isolated by differential centrifugation. The mitochondrial pellet was resuspended in SEM buffer (250 mM sucrose, 1 mM EDTA, 10 mM 3-(*N*-morpholino)propanesulfonic acid (MOPS)--KOH, pH 7.2), and the concentration was determined by Bradford assay and adjusted to a concentration of 10 mg/ml. Isolated mitochondria were aliquoted, snap-frozen in liquid nitrogen, and stored at −80°C.

Cellular and submitochondrial localization of Ste23
---------------------------------------------------

For cellular fractionation, yeast cells were homogenized and centrifuged at 20,000 × *g* at 4°C. The supernatant was subjected to two additional centrifugation steps, followed by centrifugation at 100,000 × *g* for 1 h. The resulting supernatant (S100) contains mainly cytosolic proteins and the pellet (P100) mainly the microsomal fraction. The pellet was resuspended in EM buffer (1 mM EDTA, 10 mM MOPS-KOH, pH 7.2). Alkaline treatment of mitochondria was performed in 100 mM Na~2~CO~3~, pH 11.5. Swelling of mitochondria was performed in EM buffer. Lysis of mitochondria was performed in SEM buffer containing 1% (vol/vol) Triton X-100. All fractions were analyzed via SDS--PAGE and immunoblotting.

Generation of radiolabeled preproteins and in organello import
--------------------------------------------------------------

For generation of radiolabeled Sod2 precursors, the gene was amplified from yeast genomic DNA by PCR using forward primers with SP6 promoter sequences. For generation of \[^35^S\] Ste23, the open reading frame was cloned into the pRS416 plasmid. The change of A157G in the coding sequence was generated by site-directed mutagenesis, yielding the plasmid pRS416_Ste23^M53A^, which was used as template for PCR. Sod2 and Ste23 radiolabeled preproteins were synthesized by in vitro transcription/translation using the rabbit reticulate lysate system (Promega) in the presence of ^35^S-methionine. Import of \[^35^S\]Ste23 precursor into isolated mitochondria was performed in import buffer (3% \[wt/vol\] bovine serum albumin, 10 mM MOPS-KOH, pH 7.2, 250 mM sucrose, 80 mM KCl, 5 mM MgCl~2~, 5 mM KH~2~PO~4~, 2 mM ATP, 2 mM NADH) and terminated by addition of 1% (vol/vol) AVO mix (8 μM antimycin A, 1 μM valinomycin, 20 μM oligomycin). Nonimported \[^35^S\]Ste23 was removed by PK treatment (50 µg/ml PK for 10 min on ice, followed by inhibition with 1 mM PMSF), and mitochondria were reisolated by centrifugation at 20,000 × *g* at 4°C. Mitochondrial samples were analyzed by SDS--PAGE and visualized by digital autoradiography.

Preprotein processing and peptide degradation assays in soluble mitochondrial extracts
--------------------------------------------------------------------------------------

For preprotein processing, isolated mitochondria were solubilized in reaction buffer (250 mM sucrose, 10 mM MOPS-KOH, pH 7.2, 80 mM KCl, 5 mM MgCl~2~, 5 mM KH~2~PO~4~) or 4-(2-hydroxyethyl)-1-piperazine­ethanesulfonic acid (HEPES) buffer (20 mM HEPES-KOH, pH 8.0, 10 mM MgCl~2~) containing 1% (vol/vol) digitonin for 15 min on ice and then centrifuged at 16,000 × *g* for 10 min at 4°C. For peptide degradation assays, mitochondria were subjected to sonication (five times 30 s with 30-s breaks on ice; Sonifier250, Branson) in reaction buffer, followed by centrifugation at 100,000 × *g* for 45 min at 4°C. The obtained supernatants after sonication or digitonin solubilization were incubated with different peptides (presequence amino acids 1--18 of yeast Sod2^preseq^ MFAKTAAANLTKKGGLSL and presequence amino acids 1--17 of yeast Cox4^preseq^ MLSLRQSIRFFKPATRT, with an additional cysteine residue at the C-terminus for generation of antiserum) or radiolabeled Sod2 precursor in the presence of 10 μM Cox4^preseq^ peptides. Reactions were terminated by addition of 4× Laemmli buffer (8% \[wt/vol\] SDS, 0.08% \[wt/vol\] bromophenol blue, 40% \[vol/vol\] glycerol, 240 mM Tris-HCl, pH 6.8) containing 5% (vol/vol) β-mercaptoethanol and analyzed by SDS--PAGE, followed by autoradiography and immunodecoration. Degradation kinetics was established for each different metabolic condition and every precursor individually. For cell-free translation of Ste23^WT^ and Ste23^E121Q^ with a C-terminal hexahistidine tag (mutation generated by site-directed mutagenesis in the pRS416 vector), the RTS100 wheat germ system (5PRIME) was used.

Generation and affinity purification of antisera
------------------------------------------------

For generation of antisera against the Ste23 protein and the presequences of Sod2 and Cox4, the following peptides were coupled to keyhole limpet hemocyanin via N- or C-terminal cysteine residues and rabbits immunized: Ste23 Cys-KDFEISAPPKLNNSSESE, amino acids 1--16 of Sod2 presequence (Sod2^preseq^), and amino acids 1--17 of Cox4 presequence (Cox4^preseq^). For affinity purification of antisera, corresponding peptides were reduced using Tris (2-carboxyethyl) phosphine and covalently immobilized to agarose beads (Sulfolink Coupling Resin). Peptide-coupled resin was washed, equilibrated, and incubated with protein-specific antiserum. The resin-bound antibodies were eluted with elution buffer containing 0.2 M glycine-HCl (pH 2.2), and eluted fractions were neutralized by 1 M Tris-HCl, pH 8.8. A complete list of antibodies used in this study is given in Supplemental Table S2.

Statistical analysis
--------------------

Western blots were developed with the LAS 4000 system (Fujifilm). Quantified data are shown as mean ± SEM and were obtained from three independent experiments.
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